Alice A. Larson

4.7k total citations
132 papers, 4.0k citations indexed

About

Alice A. Larson is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, Alice A. Larson has authored 132 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Cellular and Molecular Neuroscience, 89 papers in Physiology and 54 papers in Molecular Biology. Recurrent topics in Alice A. Larson's work include Pain Mechanisms and Treatments (81 papers), Neuropeptides and Animal Physiology (49 papers) and Neuroscience and Neuropharmacology Research (41 papers). Alice A. Larson is often cited by papers focused on Pain Mechanisms and Treatments (81 papers), Neuropeptides and Animal Physiology (49 papers) and Neuroscience and Neuropharmacology Research (41 papers). Alice A. Larson collaborates with scholars based in United States, Hungary and Sweden. Alice A. Larson's co-authors include Alvin J. Beitz, Stephen R. Skilling, David H. Smullin, Katalin J. Kovács, Jun Li, Donald A. Simone, James E. Madl, Kelley F. Kitto, Dénes Budai and George L. Wilcox and has published in prestigious journals such as Journal of Neuroscience, The Journal of Physiology and The Journal of Comparative Neurology.

In The Last Decade

Alice A. Larson

132 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alice A. Larson United States 35 2.3k 2.2k 1.3k 469 469 132 4.0k
S. Bourgoin France 45 4.2k 1.8× 2.8k 1.3× 2.1k 1.7× 309 0.7× 410 0.9× 160 5.8k
Bradley K. Taylor United States 37 1.6k 0.7× 2.5k 1.2× 1.1k 0.9× 309 0.7× 557 1.2× 122 4.2k
P.M. Headley United Kingdom 33 2.5k 1.1× 2.0k 0.9× 1.5k 1.2× 164 0.3× 364 0.8× 99 3.8k
Kyungsoon Chung United States 46 2.4k 1.1× 4.0k 1.8× 1.4k 1.1× 231 0.5× 803 1.7× 87 5.9k
Stephen T. Meller United States 36 1.8k 0.8× 3.3k 1.5× 885 0.7× 230 0.5× 961 2.0× 72 5.0k
Tatsuro Kohno Japan 29 2.4k 1.0× 3.7k 1.7× 1.4k 1.1× 277 0.6× 853 1.8× 77 5.2k
Abdelkrim Alloui France 35 1.3k 0.6× 2.2k 1.0× 2.2k 1.7× 259 0.6× 562 1.2× 53 4.5k
Esther L. Sabban United States 45 2.2k 0.9× 1.3k 0.6× 1.9k 1.5× 266 0.6× 267 0.6× 164 5.9k
Jan de Vente Netherlands 46 2.2k 1.0× 2.2k 1.0× 2.8k 2.2× 429 0.9× 878 1.9× 159 6.8k
Hiroko Togashi Japan 36 1.7k 0.7× 1.0k 0.5× 1.0k 0.8× 412 0.9× 374 0.8× 183 4.4k

Countries citing papers authored by Alice A. Larson

Since Specialization
Citations

This map shows the geographic impact of Alice A. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice A. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice A. Larson more than expected).

Fields of papers citing papers by Alice A. Larson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice A. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice A. Larson. The network helps show where Alice A. Larson may publish in the future.

Co-authorship network of co-authors of Alice A. Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Alice A. Larson. A scholar is included among the top collaborators of Alice A. Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice A. Larson. Alice A. Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kovács, Katalin J., et al.. (2014). After a cold conditioning swim, UCP2-deficient mice are more able to defend against the cold than wild type mice. Physiology & Behavior. 135. 168–173. 1 indexed citations
2.
Larson, Alice A., et al.. (2013). Review of Overlap Between Thermoregulation and Pain Modulation in Fibromyalgia. Clinical Journal of Pain. 30(6). 544–555. 25 indexed citations
3.
Kovács, Katalin J., et al.. (2013). Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors. Pharmacological Research. 79. 21–27. 54 indexed citations
4.
Kovács, Katalin J. & Alice A. Larson. (2006). Mast cells accumulate in the anogenital region of somatosensory thalamic nuclei during estrus in female mice. Brain Research. 1114(1). 85–97. 11 indexed citations
5.
Fang, Ming, et al.. (2003). Thrombin Inhibits NMDA‐Mediated Nociceptive activity in the Mouse: Possible Mediation by Endothelin. The Journal of Physiology. 549(3). 903–917. 28 indexed citations
6.
7.
McCarson, Kenneth E., et al.. (2002). Upregulation of neurokinin‐1 receptor expression in rat spinal cord by an N‐terminal metabolite of substance P. European Journal of Neuroscience. 16(2). 229–241. 14 indexed citations
8.
Li, Jun, Donald A. Simone, & Alice A. Larson. (1999). Windup leads to characteristics of central sensitization. Pain. 79(1). 75–82. 270 indexed citations
10.
Hornfeldt, Carl S., Kelley F. Kitto, & Alice A. Larson. (1996). Evidence that the NH2-terminus of substance P modulates N-methyl-d-aspartate-induced activity by an action involving σ receptors. European Journal of Pharmacology. 306(1-3). 15–22. 17 indexed citations
11.
Larson, Alice A., et al.. (1996). The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 662–667. 34 indexed citations
12.
Kovács, Katalin J. & Alice A. Larson. (1995). Discrepancies in characterization of σ sites in the mouse central nervous system. European Journal of Pharmacology. 285(2). 127–134. 12 indexed citations
13.
Hornfeldt, Carl S. & Alice A. Larson. (1994). Adenosine Receptors are not Involved in Theophylline-Induced Seizures. Journal of Toxicology Clinical Toxicology. 32(3). 257–265. 15 indexed citations
15.
Hornfeldt, Carl S., et al.. (1992). Antinociceptive effects of intrathecal taurine and calcium in the mouse. Life Sciences. 50(24). 1925–1934. 19 indexed citations
16.
Krumins, Solveig A., et al.. (1990). Substance P modulation of DAMGO binding in the brain of CXBK and Swiss-Webster mice. Peptides. 11(2). 281–285. 4 indexed citations
17.
Hornfeldt, Carl S. & Alice A. Larson. (1990). Seizures induced by fluoroacetic acid and fluorocitric acid may involve chelation of divalent cations in the spinal cord. European Journal of Pharmacology. 179(3). 307–313. 34 indexed citations
18.
Larson, Alice A.. (1988). Desensitization to intrathecal substance P in mice: possible involvement of opioids. Pain. 32(3). 367–374. 33 indexed citations
19.
Larson, Alice A.. (1981). Changes in pain-reflexes after intrathecal administration of tryptamine HCl in the rat. Federation Proceedings. 40. 4 indexed citations
20.
Larson, Alice A.. (1980). Inhibition by ketamine HCL and phencyclidine HCL of dorsal root potentials (DRPs) evoked by stimulation of the nucleus raphe magnus. 22(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026